A comparative evaluation of C-reactive protein as a short-term prognostic marker in severe unstable angina - A preliminary study

Journal of Association of Physicians of India

Volumn 51, Issue APR, 2003, Pages 349-354

  Bhagat, S ^a   Gaiha, M ^a   Sharma, V K ^a   Anuradha, S ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0037714528     PISSN: 00045772     EISSN: 00045772     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lincoff AM, Teheng JE, Califf RM, et al. Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIa blockade with abciximab: one year outcome in the EPILOG trial. Circulation 1999;99:1951-8.
2. Gibson CM, Goel M, Cohen DJ, et al. Six month angiographic and clinical follow up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. J Am Coll Cardiol 1998;32:28-34.
3. Braunwald E, Mark DB, Jones RH, et al. Unstable angina: Diagnosis and management. Clinical Practice Guideline number 10 (amended) AHCPR Publication No.94-0602, Rockville, Md., AHCPR and the National Heart, Lung and Blood Institute, PHS, US Department of Health and Human Services, May 1994.
4. van der Wal AC, Becker AE, van der Loos CM et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
5. Gogna A, Sinha RSK, Gupta B. C-reactive protein - marker for atherothrombotic events. J Assoc Physicians India 1999;47:818-20.
6. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in 'active' coronary artery disease. Am J Cardiol 1990;65:168-72.
7. Liuzzo G, Biasucci LM, Buffon A, et al. Elevated C-reactive protein at discharge and at 3 months after waning of symptoms in unstable angina is associated with recurrence of instability during 12 months follow up. J Am Coll Cardiol 1995;(Suppl 250A), Abstract.
8. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
9. Morrow DA, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes. A TIMI II A sub study. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998;31:1460-5.
10. WHO Expert Committee on Biological Standardization. WHO Technical Report Series 760, Geneva, Switzerland 1987.
11. Liuzzo G, Biasucci LM, Rebuzzi AG, et al. Plasma protein acute phase response in unstable angina is not induced by ischemic injury. Circulation 1996;94:2373-80.
12. Haverkate F, Thompson SG, Pyke SD, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997;349:462-6.
13. Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999;99:855-60.
14. Stone PH, Thompson B, Zaret BL, et al. Factors associated with failure of medical therapy in patients with unstable angina and non-Q-wave myocardial infarction: a TIMI-III B database study. Eur Heart J 1999;20:1084-93.